Melioidosis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — Use an intensive IV phase with ceftazidime or meropenem, followed by oral trimethoprim-sulfamethoxazole eradication therapy
The best answer is “Use an intensive IV phase with ceftazidime or meropenem, followed by oral trimethoprim-sulfamethoxazole eradication therapy”. Severe disseminated melioidosis requires a parenteral intensive phase—meropenem is favoured in critical illness, while ceftazidime is another established agent—then a prolonged eradication phase, usually trimethoprim-sulfamethoxazole, to prevent relapse. Short therapy and aminoglycoside monotherapy are ineffective.
Reference: Northern Territory Health: Melioidosis: https://health.nt.gov.au/health-alerts/melioidosis